Aktiespot

Clinical Laserthermia Systems AB (publ) (Clinical Laserthermia Systems A) Aktie

CLS-B.ST

kr3.6150+0.0350 (+0.98%)
Chart wird geladen...

Clinical Laserthermia Systems A

Eröffnung3.6050
Hoch3.7700
Tief3.5600
Volumen25.08k
P/EN/A
Marktkapitalisierung112.67M
52-Wochen-Hoch13.3600
52-Wochen-Tief2.6000
Durchschn. Volumen98.22k
DividendeN/A
Beta0.01
EPS-1.1000

Über Clinical Laserthermia Systems AB (publ) (Clinical Laserthermia Systems A) Aktie

Clinical Laserthermia Systems AB (publ) engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden. It offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. The company also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers that provides multiple options to control treatment. In addition, it offers various gauge laser applicators and introducers, as well as provides temperature and treatment monitoring devices. The company has a strategic partnership with ClearPoint Neuro Inc. for the development of ClearPoint Prism, a Neuro Laser Therapy System. Clinical Laserthermia Systems AB (publ) was incorporated in 2006 and is headquartered in Lund, Sweden.

Unternehmensinformationen

Börse: Stockholm (STO)
Sektor: Sundhed
Branche: Medicinsk udstyr
Adresse:
Building 405
223 81 Lund, Sweden
Telefon: + 46 46 15 21 00

Analystenempfehlungen

Diese Übersicht gibt einen schnellen Einblick, wie Analysten das Aktienpotenzial basierend auf ihren neuesten Analysen und Kurszielen bewerten.

Niedrigstes Kursziel
8.50
135.1%
Durchschnittliches Kursziel
8.50
135.1%
Median Kursziel
8.50
135.1%
Höchstes Kursziel
8.50
135.1%

Andere sehen auch: